Marrone Bio Innovations announces exercise of over-allotment option in public offering
Marrone Bio Innovations announced the underwriter of its previously announced public offering of registered shares of the Company’s common stock has fully exercised its option to purchase an additional 1,091,250 shares of common stock from the Company at the public offering price of $1.65 per share. April 26, 2018